Clinical trial
Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in…
NCT00136032 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00136032 |
|---|---|
| Title | Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women |
| Official title | Gender-Specific Effects of Physiologic GH Administration on Cardiovascular Risk Factors in Women With Growth Hormone Deficiency |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Growth Hormone Deficiency |
| Intervention type | Drug |
| Interventions | Somatropin, Placebo |
| Enrollment | 63 |
| Start date | Jan 1, 2002 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Aug 26, 2005 |
| Last update posted | Feb 18, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: